Neuro-Oncology News

Complete macroscopic excision of the primary tumor after induction chemotherapy appeared to improve survival outcomes among children with stage 4 high-risk neuroblastoma, according to study results published in Journal of Clinical Oncology.

Four institutions have become members of the Pediatric Brain Tumor Consortium.

Adults who received radiation therapy during childhood for abdominal and pelvic cancers appeared more likely than the general population to experience body composition abnormalities and worse cardiometabolic outcomes, study results showed.

The FDA granted fast track designation to paxalisib for the treatment of patients with newly diagnosed glioblastoma, according to a manufacturer-issued press release.

The most common type of pediatric central nervous system tumor, low-grade glioma, typically grows slowly and follows a relatively indolent course.

An unsupervised, automated machine learning algorithm successfully identified glioblastoma tumor cells and stratified survival outcomes, according to study results published in eLife.

Black children with solid cancers appeared less likely to receive proton radiotherapy than their white counterparts, according to an analysis of Children’s Oncology Group trial data published in a research letter in JAMA Oncology.

Today is Glioblastoma Awareness Day.

The FDA granted fast track designation to enzastaurin for the treatment of patients with newly diagnosed glioblastoma, according to a press release from the agent’s manufacturer.

Young adults with early-onset cancers appeared at increased risk for harboring specific germline mutations, according to study results presented at the American Association for Cancer Research Virtual Annual Meeting II.